Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 3:21 PM ET

Date/Time Source News Release
04/30/2025 08:31 AM EDT PR Newswire Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025
04/24/2025 08:01 AM EDT PR Newswire NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD
04/11/2025 09:23 AM EDT PR Newswire Lucid Diagnostics Announces Closing of Public Offering of Common Stock
04/09/2025 07:24 PM EDT PR Newswire Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
04/03/2025 09:00 AM EDT PR Newswire Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
03/27/2025 08:01 AM EDT PR Newswire Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology
03/25/2025 08:01 AM EDT PR Newswire PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
03/24/2025 08:01 AM EDT PR Newswire Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
03/20/2025 08:31 AM EDT PR Newswire Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening
03/18/2025 08:31 AM EDT PR Newswire Lucid Diagnostics' ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
Page